Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors
US8877763B2 · kind B2 · utility
1Cited by
2References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 15, 2013 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Mar 15, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I) and methods for inhibiting kinases, including spleen tyrosine kinases, are disclosed. Also disclosed are methods for treating a kinase-mediated disease or condition by administering to a subject a therapeutically effective amount of the compound of Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.